Institute for Cancer Research

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Kjetil TaskénInstitute Head
Kjetil Taskén
Institute Head

Scientific production - Institute for Cancer Research

 PublicationsDoctoral theses
2018 so far 
 2016228 15

Annual report 2016 (pdf):
download in single page format - double page (broad) format

Page visits: 189982

Current news and events

Novel subtype-specific prognostic associations of KRAS and BRAF mutations revealed in colorectal cancer

First author Jørgen Smeby with co-author Ina A. Eilertsen
First author Jørgen Smeby with co-author Ina A. Eilertsen

In a recent publication in Annals of Oncology (journal impact factor 11.9) by Jørgen Smeby and colleagues in the Lothe lab at the Department of Molecular Oncology, integration of gene expression-based subtyping and microsatellite instability status led to discovery of novel subtype-specific prognostic associations of the thoroughly investigated KRAS and BRAFV600E mutations in primary colorectal cancer (CRC).


Jon Amund Kyte "Researcher of the Month"

Jon Amund Kyte (photo: Elin B. Øvrebø)
Jon Amund Kyte (photo: Elin B. Øvrebø)

Jon Amund Kyte, leader of the "Translational cancer immunotherapy" project group at the Department of Cancer Immunology at the Institute for Cancer Research, was appointed "Researcher of the Month" for February 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF). 
The group aims to develop improved cancer treatment based on two particularly promising strategies for immunotherapy. This research is presented in a feature article published on the home page of Helse Sør-Øst.




King Olav V´s Cancer Research Prize for 2018 to Vessela Kristensen

King Olav V's cancer research award for 2018 goes to professor Vessela Kristensen, head of the Cancer Genome Variation Group at the Department of Cancer Genetics at the Institute for Cancer Research.

The prestigious prize will be handed over by HM Kong Harald V on behalf of the Norwegian Cancer Society in Oslo on April 16th. 


International Women's day, March 8th 2018:The Challenges women face in pursuing a career in STEM (science/technology/engineering/mathematics)

Guro E. Lind (photo: Terje Heiestad)
Guro E. Lind (photo: Terje Heiestad)
Global Engage has interviewed Guro E. Lind, group leader at the Department of Molecular Oncology.
"In order to achieve gender balance we should focus on why the system is failing recruiting the brilliant young female scientists, rather than discuss what the females should do to increase their chances of a scientific career. It is nothing wrong with our education, skill set or ambitions - it is the system that is flawed"    

Standardization of methodology leads to innovation

Heidi D. Pharo
Heidi D. Pharo

The Epigenetics Group at the Department of Molecular Oncology, headed by Guro E. Lind, has developed a robust internal control for DNA methylation analyses by droplet digital PCR (ddPCR). The findings have recently been published in the journal Clinical Epigenetics. First author is Heidi Dietrichson Pharo.



OUH research seminar, Monday, March 5th, 2018, at 14:30 – 16:00Tissue engineering and regenerative medicine

Welcome to the next Oslo University Hospital (OUH) research seminar entitled
Tissue engineering and regenerative medicine

Time: Monday, March 5th, 2018, 14:30 – 16:00
Place: Red Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo

Speakers: Joel Glover, Kamal Babikeir Eln Mustafa, Shadab Abadpour, Rick Siller